1. Home
  2. ALMU vs ELDN Comparison

ALMU vs ELDN Comparison

Compare ALMU & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeluma Inc.

ALMU

Aeluma Inc.

HOLD

Current Price

$12.92

Market Cap

257.6M

Sector

Technology

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.00

Market Cap

229.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALMU
ELDN
Founded
2019
2004
Country
United States
United States
Employees
14
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.6M
229.3M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ALMU
ELDN
Price
$12.92
$3.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$25.50
$8.50
AVG Volume (30 Days)
601.1K
1.3M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.67
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.96
N/A
Revenue Next Year
$73.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.79
$1.35
52 Week High
$25.88
$4.60

Technical Indicators

Market Signals
Indicator
ALMU
ELDN
Relative Strength Index (RSI) 39.59 57.82
Support Level $11.82 $2.48
Resistance Level $14.16 $3.17
Average True Range (ATR) 0.91 0.23
MACD -0.07 -0.02
Stochastic Oscillator 27.96 63.55

Price Performance

Historical Comparison
ALMU
ELDN

About ALMU Aeluma Inc.

Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: